Skip to content
Monday 31 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
+0.29%
DAX
26,295.88
-1.03%
CAC 40
8,356.63
-0.53%
STOXX 50
6,431.90
-0.83%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Saturday 03 October 2020 9:16 am

Covid-19 vaccine could be rolled out across the UK in less than three months

By: Michael Searles

Add as a preferred source on Google
ITALY-HEALTH-VIRUS-SCIENCE-TECHNOLOGY-PHARMACEUTICALS-VACCINE-MA

A Covid-19 vaccine could be rolled out across the UK by the end of the month, government scientists have reportedly said.

Those working on the AstraZeneca vaccine in Oxford are hoping that regulators approve it within the next three months, The Times reported.

A mass roll-out could happen quicker than expected, according to the report, which said that every adult could receive a dose of the vaccine within six months, while children would be excluded.

It comes after the European Medicines Agency (EMA) said on Thursday it had started reviewing data on the University of Oxford and AstraZeneca vaccine in real time, in order to speed up any approval process for it across the continent.

It is currently in the final phase of clinical trials, despite being temporarily paused at the start of September after one participant suffered adverse side effects.

The vaccine candidate is seen as leading the race among other possible Covid-19 vaccines and could be the first approved in Europe.

If it is successfully approved, the government will also consider allowing a much wider group of healthcare staff to administer the vaccine as part of its immunisation programme.

This would involve drive-through vaccination centres and recruiting the help of armed forces.

Read more

ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus
  • London business

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jaguar reveals the Type 01’s screen-free interior

  • City firms mandate phone and face-to-face comms bootcamps for Gen Z lawyers

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Jamie Vardy bags Bundesliga rights as he steps up streaming war with Neville and Lineker

More from Morning Wire

  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Astrazeneca explores $400bn megadeal with US rival 

    Markets
    AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.
  • Astrazeneca share price tumbles on $400bn megamerger talks

    Investing
    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
  • As it happened: UK stocks cool after Astrazeneca drags; Trump and Iran clash over peace talks

    FTSE 100 Live
    Donald Trump speaking at a desk, gesturing with hands, wearing a dark suit and red tie.
  • Astrazeneca and Jaguar Land Rover given power to endorse talented migrants for visas

    Politics
    Jonathan Reynolds addressing the SMMT's annual International Automotive Summit (image courtesy of SMMT)
  • UK debt ‘hits £3 trillion’ milestone

    Economics
    Houses of Parliament in Westminster showcasing historic architecture under a clear sky, central to UK government and politics
  • Heathrow overtaken by Istanbul as Europe’s busiest airport

    Transport & Infrastructure
    Commercial airplane landing at Heathrow Airport, seen from behind, with a prominent Heathrow sign below.
  • ISG Event to Spotlight Strategies for the AI-Driven Autonomous Enterprise

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook